Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The authors argue for national standardization and cut-off validation of HbA1c rather than its replacement by glucose-based alternatives for diabetes diagnosis in India.
We read with interest the article by Samajdar et al., which questions the reliability of HbA1c for diagnosing and monitoring diabetes in Indian populations.1 While the authors raise valid concerns regarding hematological confounders, we believe their conclusions overstate the case against HbA1c and insufficiently address the major limitations of the glucose based alternatives in diabetes diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Sutirtha Chakraborty (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: